0002107143-26-000001.txt : 20260721 0002107143-26-000001.hdr.sgml : 20260721 20260721103102 ACCESSION NUMBER: 0002107143-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260721 DATE AS OF CHANGE: 20260721 EFFECTIVENESS DATE: 20260721 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InterAct Therapeutics, Inc. CENTRAL INDEX KEY: 0002107143 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-591571 FILM NUMBER: 261188733 BUSINESS ADDRESS: STREET 1: 3060 PEGASUS PARK DRIVE STREET 2: BUILDING 6 CITY: DALLAS STATE: TX ZIP: 75247 BUSINESS PHONE: 2107102867 MAIL ADDRESS: STREET 1: 3060 PEGASUS PARK DRIVE STREET 2: BUILDING 6 CITY: DALLAS STATE: TX ZIP: 75247 D 1 primary_doc.xml X0708 D LIVE 0002107143 InterAct Therapeutics, Inc. 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX TEXAS 75247 2107102867 DELAWARE None None Corporation true 2025 Daniel Hargrove 3060 PEGASUS PARK DRIVE BUILDING 6 Dallas TX TEXAS 75247 Executive Officer Director Mr. Hargrove is the CEO and a director of the Issuer. Isaac Chan 3060 PEGASUS PARK DRIVE BUILDING 6 Dallas TX TEXAS 75247 Director Dr. Chan is a director of the Issuer Other Health Care Decline to Disclose 06b false 2026-07-20 false true false 0 2000000 250000 1750000 false 1 0 0 0 false InterAct Therapeutics, Inc. Tyler Dove Tyler Dove By POA from Daniel Hargrove, CEO 2026-07-21